全球醫療設備軟體市場

預計到 2030 年全球醫療設備軟體市場規模將達到 5,370 萬美元

2024 年全球醫療設備軟體市場規模估計為 2,220 萬美元，預計到 2030 年將達到 5,370 萬美元，2024 年至 2030 年的複合年成長率為 15.9%。雲端運算採用是報告中分析的細分市場之一，預計複合年成長率為 14.1%，到分析期結束時規模將達到 3,200 萬美元。在分析期內，內部配置部分預計將以 18.8% 的複合年成長率成長。

美國市場規模估計為 600 萬美元，中國市場預計複合年成長率為 20.7%

美國醫療設備軟體市場規模預計在2024年達到600萬美元。作為世界第二大經濟體的中國，預計2030年市場規模將達到1,160萬美元，在2024-2030年分析期間的複合年成長率為20.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 11.9% 和 14.1%。在歐洲，預計德國的複合年成長率約為 12.6%。

全球軟體醫療設備市場－主要趨勢與促進因素摘要

只用代碼就能治療嗎？為什麼軟體作為醫療設備將重新定義醫療保健

軟體即醫療設備(SaMD) 透過使獨立於硬體的軟體程式能夠執行診斷、治療建議和疾病監測等功能，徹底改變了醫療保健。與嵌入設備的傳統軟體不同，SaMD 可以在行動裝置、雲端平台或桌面應用程式上自主運行，從而實現遠端患者管理和數據驅動的臨床決策。從使用智慧型手機上的心電圖演算法檢測心律不整到使用預測糖尿病軟體最佳化胰島素劑量，SaMD 正在改變醫療保健的提供方式，特別是在慢性病管理、心理健康、放射學和數位治療領域。

SaMD 尤其具有顛覆性，因為它能夠大規模提供臨床能力，而無需物理製造。這種靈活性使得快速更新、迭代改進和即時數據分析成為可能——所有這些對於管理腫瘤學、神經病學和罕見疾病等複雜疾病至關重要。此外，COVID-19 疫情加速了用於遠距離診斷和數位分診的 SaMD 工具的檢驗，為 FDA 和 EMA 等監管機構建立快速核准通道鋪平了道路。對個人化、非侵入性和持續監測解決方案的需求從未如此強烈，這使得 SaMD 成為不斷發展的護理的基石。

為什麼從製藥公司到付款人的相關人員支持 SaMD？

雲端處理、人工智慧和行動技術的融合為在臨床和消費者環境中部署 SaMD 創造了肥沃的環境。製藥公司正在加速將 SaMD 整合到其藥物開發和上市後監測策略中，利用數位生物標記和真實世界數據來改善治療結果並監測患者的依從性。這些軟體解決方案還與伴隨診斷、連接藥物輸送設備和穿戴式感測器捆綁在一起，形成一個全面的數位健康生態系統。對於付款人和提供者，SaMD 提供早期檢測、風險分層和介入的工具，從而降低住院率並提高成本效益。

監管機構正在透過建立確保患者安全且不抑制創新的框架來應對。 FDA 的數位健康軟體預認證計畫、歐盟的醫療設備法規 (MDR) 和日本的藥品和醫療設備管理局 (PMDA) 都為 SaMD 引入了簡化的途徑。這些框架強調上市後監測、以使用者為中心的設計和真實世界的效能檢驗。 SaMD 獨立於硬體運行，使其能夠跨地域快速擴展，在資源受限的醫療保健環境中特別有效。隨著基於價值的照護模式在全球的擴展，SaMD 有望成為主動、個人化醫療保健領域的核心。

人工智慧、機器學習和現實世界數據如何推動 SaMD 的發展？

人工智慧和機器學習是 SaMD 創新的核心。這些技術使軟體能夠分析大量資料集、識別模式並做出高精度的預測評估。在放射學領域，人工智慧 SaMD 可以從影像掃描中檢測出腫瘤和骨折等異常情況，其準確度可與人類專家媲美甚至超過人類專家。在心臟病學中，機器學習演算法評估心電圖訊號以尋找心律不整和心臟衰竭的指標。在行為健康領域，SaMD 解決方案經過訓練，可以透過語音模式、面部表情和數位互動數據檢測焦慮和憂鬱的早期徵兆。這些功能不僅提高了診斷的準確性，而且還能夠實現更早、更個人化的介入。

真實世界數據 (RWD) 和真實世界證據 (RWE) 進一步推動了 SaMD 的價值提案。由於軟體平台整合了穿戴式裝置、電子健康記錄和病患報告結果的數據，它成為持續學習和即時風險評估的有力工具。開發人員正在利用雲端基礎設施和聯合學習模型來提高不同人群的演算法效能，同時確保資料隱私。這樣的回饋迴路將允許監管機構核准自適應演算法——根據新證據在核准後不斷發展的 SaMD 產品。整合網路安全、HIPAA 合規性和使用者身分驗證系統可確保這些解決方案的安全可靠。

是什麼推動了醫療設備軟體的快速成長？

數位健康產業的多種協同力量推動著軟體醫療設備市場的成長。其中最重要的是，對於慢性病和文明病的遠距照護和自我管理工具的需求日益成長。隨著患者越來越依賴行動應用程式和連網平台來監測他們的健康狀況，SaMD 正在彌合臨床環境和居家照護之間的差距。此外，新興市場智慧型手機和雲端基礎設施的廣泛採用正在使 SaMD 的存取變得民主化，使服務不足的人群能夠從人工智慧主導的醫療保健解決方案中受益。

製藥和醫療技術公司正在迅速將 SaMD 納入其市場進入策略，因為他們認為這是擴大其產品治療影響和收集上市後見解的一種方式。同時，醫院和付款人正在利用 SaMD 進行自動分類、病人參與和早期檢測，以減輕急診的壓力並改善護理協調。最後，創業投資和私募股權對 SaMD新興企業的投資達到了歷史最高水平，顯示市場信心強勁。隨著醫療保健系統朝向個人化、以數據為中心、預防保健模式發展，SaMD 將成為全球醫療保健服務的臨床工具和策略差異化因素。

部分

部署（雲端、本地）、應用（篩檢和診斷、監測和警報、慢性疾病管理、數位治療、其他應用）、最終用途（醫院和診所、居家醫療、其他最終用途）

受訪公司範例（43家值得關注的公司）

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口（成品和OEM）預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家（14,949）、智庫（62）和貿易及產業協會（171）的專家意見，以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計，這種動盪將在未來幾個月內平息，新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月：談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響，並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家，他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Software as a Medical Device Market to Reach US$53.7 Million by 2030

The global market for Software as a Medical Device estimated at US$22.2 Million in the year 2024, is expected to reach US$53.7 Million by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$32.0 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 18.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Million While China is Forecast to Grow at 20.7% CAGR

The Software as a Medical Device market in the U.S. is estimated at US$6.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.6 Million by the year 2030 trailing a CAGR of 20.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Software as a Medical Device Market - Key Trends & Drivers Summarized

Can Code Alone Cure? Why Software as a Medical Device Is Rewriting Healthcare Norms

Software as a Medical Device (SaMD) is revolutionizing healthcare by allowing software programs-independent of any hardware-to perform functions such as diagnosis, treatment recommendation, or disease monitoring. Unlike traditional software embedded within devices, SaMD operates autonomously on mobile devices, cloud platforms, or desktop applications, enabling remote patient management and data-driven clinical decision-making. From detecting cardiac arrhythmias via smartphone ECG algorithms to optimizing insulin dosing through predictive diabetes software, SaMD is transforming how healthcare is delivered, particularly in chronic disease management, mental health, radiology, and digital therapeutics.

What makes SaMD particularly disruptive is its ability to deliver clinical functionality at scale without the need for physical manufacturing. This agility allows rapid updates, iterative improvements, and real-time data analysis-all essential in managing complex conditions like oncology, neurology, and rare diseases. Additionally, the COVID-19 pandemic accelerated the validation of SaMD tools for remote diagnostics and digital triage, paving the way for regulatory agencies like the FDA and EMA to establish fast-track pathways for their approval. The demand for personalized, non-invasive, and continuous monitoring solutions has never been higher, positioning SaMD as a linchpin in the evolving continuum of care.

Why Are Stakeholders from Pharma to Payers Rallying Behind SaMD?

The convergence of cloud computing, artificial intelligence, and mobile technologies has created a fertile environment for SaMD deployment across both clinical and consumer settings. Pharmaceutical companies are increasingly integrating SaMD into their drug development and post-marketing surveillance strategies, using digital biomarkers and real-world data to enhance therapeutic efficacy and monitor patient adherence. These software solutions are also being bundled with companion diagnostics, connected drug delivery devices, and wearable sensors to form comprehensive digital health ecosystems. For payers and providers, SaMD offers tools for early detection, risk stratification, and intervention that can reduce hospitalization rates and improve cost efficiency.

Regulatory bodies have responded by establishing frameworks that ensure patient safety without stifling innovation. The FDA’s Digital Health Software Precertification Program, the EU Medical Device Regulation (MDR), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) have introduced streamlined pathways tailored for SaMD. These frameworks emphasize post-market surveillance, user-centric design, and real-world performance validation. SaMD’s ability to operate independently of hardware allows it to scale rapidly across geographies, making it especially effective in resource-constrained healthcare settings. As value-based care models expand globally, SaMD is poised to become a core enabler of proactive, personalized healthcare.

How Are AI, Machine Learning, and Real-World Data Powering SaMD Evolution?

Artificial intelligence and machine learning are at the heart of SaMD innovation. These technologies allow software to analyze vast datasets, identify patterns, and make predictive assessments with high precision. In radiology, AI-powered SaMD can detect abnormalities such as tumors or fractures from imaging scans with accuracy comparable to or exceeding human specialists. In cardiology, ML algorithms assess ECG signals for arrhythmias or heart failure indicators. In behavioral health, SaMD solutions are being trained to detect early signs of anxiety or depression through speech patterns, facial expressions, and digital interaction data. These capabilities are not just enhancing diagnostic accuracy but enabling earlier and more personalized interventions.

Real-world data (RWD) and real-world evidence (RWE) are further propelling the value proposition of SaMD. As software platforms integrate data from wearables, electronic health records, and patient-reported outcomes, they become powerful tools for continuous learning and real-time risk assessment. Developers are leveraging cloud infrastructure and federated learning models to ensure data privacy while improving algorithmic performance across diverse populations. This feedback loop is enabling regulatory agencies to approve adaptive algorithms-SaMD products that evolve post-approval based on new evidence. The integration of cybersecurity, HIPAA compliance, and user authentication systems ensures that these solutions remain secure and trustworthy.

What’s Fueling the Exponential Rise of Software as a Medical Device?

The growth in the software as a medical device market is driven by several synergistic forces across the digital health landscape. Chief among them is the escalating demand for remote care and self-management tools, especially in chronic and lifestyle-driven diseases. With patients increasingly relying on mobile apps and connected platforms to monitor their health, SaMD is bridging the gap between clinical settings and home-based care. Moreover, the proliferation of smartphones and cloud infrastructure in emerging markets is democratizing access to SaMD, allowing underserved populations to benefit from AI-driven healthcare solutions.

Pharmaceutical and medtech companies are rapidly incorporating SaMD into their go-to-market strategies, viewing it as a means to extend the therapeutic impact of their products and gather post-market insights. Meanwhile, hospitals and payers are leveraging SaMD for triage automation, patient engagement, and early detection to reduce the burden on emergency departments and improve care coordination. Finally, venture capital and private equity investment in SaMD startups is at an all-time high, signaling strong market confidence. As healthcare systems evolve toward personalized, data-centric, and preventive care models, SaMD is positioned to serve as both a clinical tool and a strategic differentiator in global healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Software as a Medical Device market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics, Other Applications); End-Use (Hospitals & Clinics, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• AliveCor
• Apple Inc.
• Arterys Inc.
• Biofourmis
• Brainlab
• Cerner Corporation
• Digital Diagnostics Inc.
• GE Healthcare
• Google Health
• Health Catalyst
• IBM Watson Health
• iSchemaView Inc.
• Medtronic plc
• MindMaze
• Microsoft Health
• Philips Healthcare
• Qlarity Imaging LLC
• Samsung Health
• Siemens Healthineers
• Viz.ai

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Software as a Medical Device - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Regulatory Recognition of Software-Based Therapeutics Drives Market Legitimacy and Growth
  • Accelerated Adoption of Digital Health and Remote Monitoring Expands Application Scope
  • Increased Investment in AI-Powered Diagnostics and Predictive Algorithms Fuels Innovation
  • Widespread Use in Chronic Disease Management Strengthens Clinical Integration
  • Mobile and Wearable Integration Enhances Real-Time Patient Engagement
  • Regulatory Frameworks Like FDA and EU MDR Enable Clarity and Global Expansion
  • Use in Personalized Medicine and Data-Driven Treatment Planning Expands Precision Health Opportunities
  • Mental Health and Behavioral Therapy Applications Create Rapid Adoption Pathways
  • Reimbursement Inclusion in Select Markets Drives Payor-Supported Growth
  • Cybersecurity and Data Integrity Challenges Highlight the Need for Robust Infrastructure
  • Partnerships Between Tech Startups and Medical Device Firms Accelerate Product Development
  • Rise in Clinical Validation and Real-World Evidence Collection Strengthens Market Trust
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Software as a Medical Device Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Screening & Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Monitoring & Alerting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION